Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle.

To understand the molecular mechanism of carcinogenesis in androgen-dependent tumors, we have searched for new markers which are associated with this process. In normal rat prostate and seminal vesicle, sulfated glycoprotein 2 (SGP-2) messenger RNA is barely detectable. However, we have found high levels of SGP-2 expression in the epithelial component of carcinomas of the prostate and seminal vesicle after initiation with N-nitroso-N-methylurea and promotion with testosterone propionate. We have also observed induction of SGP-2 expression in epithelial cells at early stages in carcinogenesis when cytologically malignant cells first begin to appear. SGP-2 has been reported previously to be associated with a variety of models of programmed cell death (apoptosis), including the prostate following castration. Our present findings provide a novel marker for carcinogenesis in the rat prostate and seminal vesicle.

[1]  F. Mostofi,et al.  Prostatic carcinoma: problems in the interpretation of prostatic biopsies. , 1992, Human pathology.

[2]  A. Benabid,et al.  Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Sporn,et al.  Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. , 1991, Cancer research.

[4]  N. Kyprianou,et al.  Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. , 1990, Cancer research.

[5]  W. Stuart,et al.  Apolipoprotein J: structure and tissue distribution. , 1990, Biochemistry.

[6]  R. Huang,et al.  A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis , 1990, The Journal of cell biology.

[7]  J. Tschopp,et al.  Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Lehnert,et al.  Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. , 1988, Development.

[9]  C. Cheng,et al.  Rat clusterin isolated from primary Sertoli cell-enriched culture medium is sulfated glycoprotein-2 (SGP-2). , 1988, Biochemical and biophysical research communications.

[10]  T. Muramatsu,et al.  cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. , 1988, Biochemical and biophysical research communications.

[11]  M. Griswold,et al.  Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. , 1987, Biochemistry.

[12]  M. Pollard,et al.  Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone. , 1986, Journal of the National Cancer Institute.

[13]  P. Gilna,et al.  Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. , 1989, The Biochemical journal.

[14]  M. Tenniswood,et al.  Androgen‐repressed messages in the rat ventral prostate , 1986, The Prostate.

[15]  F. Mostofi,et al.  Immunopathology of Prostate and Bladder Tumors , 1985 .